GlassScriptPhysician profile
Andrew Lewis
NPI 1548005150
$1,408.18
in general payments reported to CMS, 2019-2025
10 companies · $985 in 2025
The $985 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $424 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $367.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $137.02 | 2025 | Puraply Wound Matrix, Apligraf |
| Baxter Healthcare | $135.45 | 2025 | Floseal |
| Bard Peripheral Vascular, INC. | $134.36 | 2024-2025 | Venovo |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Atricure, INC. | $110.33 | 2024 | |
| Haemonetics Corporation | $104.95 | 2024 | Teg6s Hemostasis System |
| Solventum Corporation | $101.34 | 2024 | Prevena, V.A.C.Ulta |
| Boston Scientific Corporation | $100.85 | 2025 | Ekosonic |
| Smith+Nephew, INC. | $91.26 | 2024 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.